dactinomycin and ursolic acid

dactinomycin has been researched along with ursolic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andriantsiferana, R; Cao, S; Guza, RC; Kingston, DG; Miller, JS; Rasamison, VE1
Chapuis, JC; Cichacz, Z; Craciunescu, F; Cragg, GM; Doubek, DL; Du, J; Goswami, A; Herald, CL; Hoard, MS; Hogan, F; Hooper, JN; Nogawa, T; Pettit, GR; Pettit, RK; Schmidt, JM; Searcy, J; Tackett, DN; Tackett, L; Tan, R; Williams, L; Xu, JP; Ye, QH1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

3 other study(ies) available for dactinomycin and ursolic acid

ArticleYear
Cytotoxic triterpenoids from Acridocarpus vivy from the Madagascar rain forest.
    Journal of natural products, 2004, Volume: 67, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Flowers; Humans; Inhibitory Concentration 50; Madagascar; Malpighiaceae; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oleanolic Acid; Plant Leaves; Plants, Medicinal; Triterpenes; Tumor Cells, Cultured

2004
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
    Journal of natural products, 2008, Volume: 71, Issue:3

    Topics: Antineoplastic Agents; Carbazoles; Depsipeptides; Drug Screening Assays, Antitumor; Indole Alkaloids; Marine Biology; Molecular Structure; Oxazoles; Peptides, Cyclic; Piperazines

2008
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012